Brief: Dawnrays Pharmaceutical Says ‍FY Profit For Year RMB293.0 Mln

Dawnrays Pharmaceutical (Holdings)

22/03/2018 05:37

March 22 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
 2348.HK :
    * PROPOSED FINAL DIVIDEND PER SHARE OF HK$0.12
    * FY ‍REVENUE RMB882.5 MILLION VERSUS RMB824.4 MILLION ​
    * ‍FY PROFIT FOR YEAR RMB293.0 MILLION VERSUS RMB265.9
MILLION

Source text for Eikon:  ID:nHKS8ndKhQ 
Further company coverage:  2348.HK 

 ((Reuters.Briefs@thomsonreuters.com;))